论文部分内容阅读
Hybrids of metronidazole and quinolones as antimicrobial agents were developed and their bioactive assay that the newly synthesized compounds exhibited good or even stronger antimicrobial activities against the tested strains including multi-drug resistant MRSA in comparison with reference drugs norfloxacin,chloromycin and fluconazole.Cell toxicity disclosed that highly active target compounds did not show toxicity to A549 cell line within the concentration of 256 μg/mL.